Completed PHASE1 INTERVENTIONAL 1-arm NCT01291589

HIV Prevention in Very High Risk Men Who Have Sex With Men (ENGAGE)

Sponsor: Fenway Community Health

Interventions Cognitive-behavioral therapy

Updated 5 times since 2017 Last updated: Aug 8, 2016 Started: Nov 30, 2011 Primary completion: Apr 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01291589, this PHASE1 trial focuses on Risk Reduction Behavior and remains completed. Sponsored by Fenway Community Health, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fenway Community Health
Harvard University
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: Fenway Community Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States